Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma

✍ Scribed by Daniel Keizman; Maya Ish-Shalom; Roberto Pili; Hans Hammers; Mario A. Eisenberger; Victoria Sinibaldi; Ben Boursi; Natalie Maimon; Maya Gottfried; Henry Hayat; Avivit Peer; Svetlana Kovel; Avishay Sella; Raanan Berger; Michael A. Carducci

• Book ID: 116431072
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 277 KB
• Volume: 48
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2012.02.050